Canon Medical Academy
Webinar
MRI/Ultrasound Fusion-Guided Prostate Biopsy
Canon Medical Academy
Webinar
MRI/Ultrasound Fusion-Guided
Prostate Biopsy
MRI/Ultrasound Fusion-Guided Prostate Biopsy
Join us on April 24 for the upcoming "MRI/Ultrasound Fusion-Guided Prostate Biopsy" webinar, which will be held at 7 pm CEST / 1 pm EDT.
The event will focus on MRI/ultrasound software fusion-guided prostate biopsy techniques, particularly the transperineal (TP) approach, as recommended by the European Association of Urology (EAU).
During the webinar made possible by the Canon Medical Academy, the speakers will present and discuss "how-to," tips and tricks, as well as actual results concerning detection rate, patient experience, and safety from two centers that have performed more than 500 TP MRI/ultrasound fusion-guided biopsy cases each on Canon Aplio i-series ultrasound systems equipped with Canon Smart Fusion software.
Canon Medical Academy
MRI/Ultrasound Fusion-Guided
Prostate Biopsy
April 24 | 7PM CEST
Program
Certificate*: All delegates will receive a certificate of attendance.
* Note: Full name entered by joining the live webinar will be used to generate your name on the attendance certificate.
- Introduction | Prof. Inga Peters
- Transperineal MRI Fusion-Guided Biopsy Under Local Anesthesia | Dr. Katrien Gieraerts
- Prospective Randomized FAST Trial – Higher Detection Rate with Less Biopsies? | Dr. Matthias Jahnen
- Live Q&A moderated by Prof. Inga Peters
- Learn the value of MRI fusion-guided biopsies for prostate and understand the benefits of systematic and targeted biopsy
- Learn about free-hand transperineal fusion guided prostate biopsy in daily routine
- Learn about new biopsy strategies to reduce unnecessary extracted biopsy cores
- Understand the advantages of using advanced ultrasound techniques within urology
- Participate in the live Q&A with the experts to find answers to your own questions
Certificate*: All delegates will receive a certificate of attendance.
* Note: Full name entered by joining the live webinar will be used to generate your name on the attendance certificate.
Information on Speakers and Presentations
Moderator: Prof. Inga Peters, MD, PhD Urologist, Deputy Medical Director
Krankenhaus Nordwest
Frankfurt, Germany
Krankenhaus Nordwest
Frankfurt, Germany
Discover More About the Moderator
Speaker: Dr. Katrien Gieraerts, MD Radiologist
AZ Sint-Jan Brugge AV
Bruges, Belgium
Presentation: Transperineal MRI Fusion-Guided Biopsy Under Local Anesthesia
MRI/ultrasound fusion-guided prostate biopsies in the transperineal approach have become the recommended biopsy procedure according to the guidelines of the European Association of Urology (EAU).
In our department, we established a streamlined and timesaving protocol for this approach under local anesthesia using a Canon Aplio i800 ultrasound scanner.
We have performed more than 500 biopsies with very good tolerance by the patients and a high detection rate for clinically significant cancers.
AZ Sint-Jan Brugge AV
Bruges, Belgium
Presentation: Transperineal MRI Fusion-Guided Biopsy Under Local Anesthesia
MRI/ultrasound fusion-guided prostate biopsies in the transperineal approach have become the recommended biopsy procedure according to the guidelines of the European Association of Urology (EAU).
In our department, we established a streamlined and timesaving protocol for this approach under local anesthesia using a Canon Aplio i800 ultrasound scanner.
We have performed more than 500 biopsies with very good tolerance by the patients and a high detection rate for clinically significant cancers.
Discover More About the Speaker
Speaker: Dr. Matthias Jahnen, MD Urology, Senior Resident
University Hospital Rechts der Isar, Technical University Munich
Munich, Germany
Presentation: Prospective Randomized FAST Trial – Higher Detection Rate with Less Biopsies?
Improvements in MRI, ultrasound, and fusion technology have led to increased accuracy in prostate biopsies. As a result, biopsy strategies aimed at reducing the number of biopsy cores have been increasingly discussed. A less invasive biopsy could lead to less pain during the biopsy, fewer complications, and less detection of insignificant prostate cancers.
This presentation will discuss the current guidelines and research, including the prospective FAST trial, which focuses on reducing unnecessary biopsy cores.
University Hospital Rechts der Isar, Technical University Munich
Munich, Germany
Presentation: Prospective Randomized FAST Trial – Higher Detection Rate with Less Biopsies?
Improvements in MRI, ultrasound, and fusion technology have led to increased accuracy in prostate biopsies. As a result, biopsy strategies aimed at reducing the number of biopsy cores have been increasingly discussed. A less invasive biopsy could lead to less pain during the biopsy, fewer complications, and less detection of insignificant prostate cancers.
This presentation will discuss the current guidelines and research, including the prospective FAST trial, which focuses on reducing unnecessary biopsy cores.
Discover More About the Speaker
Discover More About the Moderator and Speakers
Prof. Inga Peters, MD, PhDProf. Inga Peters is a urologist and professor specializing in robot-assisted surgery and uro-oncology. She currently serves as Deputy Medical Director and Chief Physician of Urology at Krankenhaus Nordwest in Frankfurt.
Previously, Dr. Peters has held leadership roles at the Medical University of Hannover, including Head of the Prostate Cancer Center, and has conducted significant research on renal cell carcinoma and prostate cancer.
Prof. Peters is an active member of several prominent urological societies and is committed to teaching and leadership in medicine.
Dr. Katrien Gieraerts, MDDr. Katrien Gieraerts is a radiologist at the Radiology Department of AZ Sint-Jan General Hospital in Bruges, Belgium.
She is an expert in mammography, ultrasound, and ultrasound-guided biopsies, including fusion-guided biopsies.
In close cooperation with the urologists, she has also focused on MRI-TRUS fusion-guided transperineal prostate biopsies during the last few years.
Dr. Matthias Jahnen, MDDr. Matthias Jahnen is an experienced physician at the University Hospital Rechts der Isar, Technical University of Munich.
His research and clinical work focus on improving biopsy strategies in men with suspected prostate cancer. He has extensive experience in transrectal and perineal prostate biopsies under local anesthesia.
He is the principal investigator of the FAST trial, a prospective randomized trial aimed to reduce unnecessary systematic biopsy cores by using frozen section analysis-assisted targeted prostate biopsy.
Other webinars that may interest you
MRI Webinars Ultrasound Webinars
Disclaimers
Due to medical device regulatory reasons, not all products/services displayed on this Canon Medical Systems webpage are available in all countries or markets. Future availability of the products/service cannot also be guaranteed. Don't hesitate to contact your local Canon Medical Systems representative for further details.
